GO:0000994 RNA polymerase III core binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000994 (RNA polymerase III core binding) is a molecular function describing the selective binding of a protein to the core enzyme of eukaryotic RNA polymerase III, a 17-subunit nuclear polymerase dedicated to short noncoding RNAs such as tRNAs and 5S rRNA.
• The RNA polymerase III core is a multisubunit assembly whose structural organization has been resolved by cryo-electron microscopy, revealing conserved subunits and regulatory modules.
• Binding to the Pol III core is a prerequisite for transcription initiation, elongation and termination, and it is mechanistically distinct from holoenzyme-dependent termination.
• Regulation of Pol III core binding and recruitment is responsive to cellular growth signals and can be modulated by factors such as Maf1 and progesterone receptor.
• Dysregulated Pol III transcription and its core-binding factors are linked to cancer, metabolic disease and neurological disorders, making GO:0000994 a relevant node for disease modeling.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal interrogation of genes encoding Pol III core subunits and their binding partners.
Description
GO:0000994, RNA polymerase III core binding, is a molecular function term that captures the physical interaction between a protein and the core enzyme of eukaryotic RNA polymerase III (Pol III). Pol III is a multisubunit nuclear enzyme typically composed of seventeen subunits that transcribes short, abundant noncoding RNAs, including tRNAs, 5S rRNA, U6 snRNA and 7SL RNA. The core enzyme represents the minimal catalytic assembly, and proteins that bind this core participate in its assembly, recruitment to chromatin, catalytic regulation and termination. Because Pol III output is tightly coupled to cell growth and biosynthetic demand, understanding core binding is central to dissecting how cells adjust translation capacity and proteostasis. From a research perspective, GO:0000994 is not merely a binding annotation; it defines a functional interface that determines whether Pol III can engage DNA, synthesize RNA and terminate correctly. Structural studies have revealed the architecture of the human Pol III core and its associated modules, providing a framework for interpreting disease-associated mutations and for designing targeted perturbations. In parallel, biochemical work has distinguished core-dependent and holoenzyme-dependent mechanisms of termination, showing that core binding can dictate distinct mechanistic outcomes. This article integrates the QuickGO definition with verified PubMed literature to summarize the mechanism, key genes, disease relevance, experimental models and CRISPR strategies relevant to RNA polymerase III core binding. It is intended for researchers who need a precise, citable overview of GO:0000994 and practical guidance on how to study it.
RNA polymerase III core binding At A Glance
| GO ID | GO:0000994 |
|---|---|
| GO term | RNA polymerase III core binding |
| Ontology | molecular_function |
| Synonym | None listed in QuickGO |
| Major function | Binding to the core enzyme of eukaryotic RNA polymerase III, a 17-subunit nuclear polymerase |
| Definition source | QuickGO definition: Binding to an RNA polymerase III core enzyme, a multisubunit eukaryotic nuclear RNA polymerase typically composed of seventeen subunits |
| Biological context | Pol III core assembly, recruitment, transcription initiation/elongation/termination and growth-dependent regulation |
| Representative subunits | Core subunits of Pol III including catalytic and structural subunits described in structural studies |
| Related processes | tRNA transcription, 5S rRNA synthesis, termination, Maf1-mediated repression |
What Is GO:0000994?
In the context of the Gene Ontology, RNA polymerase III core binding (GO:0000994) is defined as the binding to an RNA polymerase III core enzyme, a multisubunit eukaryotic nuclear RNA polymerase typically composed of seventeen subunits. This term describes a molecular function: the selective, non-covalent interaction of a protein with the core Pol III complex. It excludes binding to accessory factors or to the fully assembled holoenzyme unless the core enzyme itself is the binding target. Functionally, such binding can serve to assemble, stabilize, recruit, regulate or terminate the Pol III core, and it is experimentally distinguished from holoenzyme-mediated mechanisms in the literature.
Why Is RNA polymerase III core binding Important in Cell Biology?
RNA polymerase III core binding is important because it defines the molecular interface through which cells control the production of tRNAs, 5S rRNA and other short noncoding RNAs that are essential for translation and cellular homeostasis. Perturbations in Pol III core assembly or its binding partners can alter translational capacity, stress responses and proliferation, and have been implicated in cancer and other diseases. Because the core enzyme is a multisubunit machine, understanding which proteins bind it, when and how, is fundamental to interpreting both normal physiology and disease-associated dysregulation.
• Defines a key regulatory interface for Pol III-dependent transcription of tRNAs and 5S rRNA.
• Provides a mechanistic basis for distinguishing core-dependent versus holoenzyme-dependent termination.
• Links growth signaling and transcriptional repression to Pol III core regulation, for example through Maf1.
• Supports structural interpretation of human Pol III architecture and subunit interactions.
• Offers a functional annotation for genes encoding Pol III core subunits and their binding partners.
• Enables disease modeling of Pol III dysregulation in cancer and metabolic or neurological contexts.
• Guides CRISPR-based perturbation strategies to test causality of candidate core-binding factors.
• Facilitates comparative analysis of Pol III recruitment in vivo across cell types and conditions.
Molecular Mechanism of RNA polymerase III core binding
Core enzyme architecture and subunit composition
In simple terms: The Pol III core is a large molecular machine made of many protein subunits that work together to read DNA and make short RNA molecules.
Eukaryotic RNA polymerase III is a multisubunit nuclear enzyme typically composed of seventeen subunits, and its core enzyme forms the catalytic heart of the complex. Cryo-electron microscopy studies of human Pol III have resolved the unbound and transcribing states, revealing the spatial organization of core subunits and associated modules. Complementary structural work has provided insights into transcriptional regulation of human Pol III, including how subunit interfaces contribute to catalysis and regulation. These structures define the physical surface to which core-binding proteins must dock, and they provide a template for mapping disease-associated mutations.
Assembly of the Pol III core
In simple terms: Building the Pol III core is like assembling a complex machine from many parts, and some parts may be put together even before the machine is fully finished.
Assembly of the RNA polymerase III complex involves a putative co-translational mechanism, suggesting that core subunits may begin to associate as they are synthesized. This assembly process is essential for producing a functional core enzyme capable of binding DNA and initiating transcription. Because core binding is a prerequisite for downstream recruitment and catalysis, defects in assembly can impair Pol III output and cellular translation capacity. Structural and biochemical data collectively support a model in which core subunit interactions are coordinated with the availability of accessory factors.
Recruitment of Pol III to target genes
In simple terms: Once the core is built, it must be brought to the right places in the genome to start making RNA.
Recruitment of RNA polymerase III in vivo is a regulated process that determines which Pol III target genes are transcribed under a given condition. Core-binding proteins and associated factors contribute to this recruitment by interacting with the core enzyme and with chromatin-associated machinery. The distinction between core binding and holoenzyme function is mechanistically important, as termination and regulation can proceed through core-dependent or holoenzyme-dependent routes. Thus, GO:0000994 captures an early and decisive step in the Pol III transcription cycle.
Termination and core-dependent mechanisms
In simple terms: Stopping RNA synthesis is just as important as starting it, and the core enzyme itself can play a direct role in this stopping process.
Transcription termination by eukaryotic RNA polymerase III has been studied in detail, and core versus holoenzyme mechanisms can be distinguished experimentally. Core-dependent termination involves the Pol III core enzyme and its direct interactions, whereas holoenzyme-dependent termination requires additional factors. These findings underscore that binding to the Pol III core is not only about initiation but also about termination and recycling. The mechanistic separation of core and holoenzyme pathways provides a framework for interpreting mutations that affect core-binding interfaces.
Regulation by Maf1 and growth signals
In simple terms: Cells can dial Pol III activity up or down depending on growth conditions, and proteins like Maf1 help apply the brakes.
Maf1 is a conserved repressor of Pol III transcription, and recent work shows that Maf1 cooperates with progesterone receptor to repress RNA polymerase III transcription of select tRNAs. This regulation impinges on Pol III core function and recruitment, linking core binding to hormonal and growth signaling. Because Pol III output is coupled to biosynthetic demand, regulatory inputs that modulate core binding or core-associated factors can have broad effects on translation and cell growth. These mechanisms are relevant to cancer and metabolic disease, where Pol III dysregulation is often observed.
Key Genes Involved in GO:0000994 RNA polymerase III core binding
The following genes and proteins represent core subunits, assembly factors and regulatory partners relevant to RNA polymerase III core binding (GO:0000994).
| Gene | Major Role | Research Relevance |
|---|---|---|
| POLR3A | Core subunit of RNA polymerase III | Structural and functional studies of the Pol III core |
| POLR3B | Core subunit of RNA polymerase III | Catalytic and assembly studies of Pol III |
| POLR3C | Core subunit of RNA polymerase III | Core architecture and recruitment studies |
| POLR3D | Core subunit of RNA polymerase III | Core assembly and transcription studies |
| POLR3E | Core subunit of RNA polymerase III | Structural analysis of human Pol III |
| POLR3F | Core subunit of RNA polymerase III | Core binding and regulation studies |
| POLR3G | Core subunit of RNA polymerase III | Assembly and recruitment studies |
| POLR3H | Core subunit of RNA polymerase III | Core architecture and function |
| POLR3K | Core subunit of RNA polymerase III | Termination and core-dependent mechanisms |
| POLR2E | Shared subunit with RNA polymerase II | Comparative core subunit studies |
| POLR2F | Shared subunit with RNA polymerase II | Structural comparisons of Pol III core |
| POLR2H | Shared subunit with RNA polymerase II | Core subunit interaction studies |
| POLR2L | Shared subunit with RNA polymerase II | Core assembly and evolution studies |
| MAF1 | Repressor of Pol III transcription | Regulation of Pol III core activity |
| PGR | Progesterone receptor, cooperates with Maf1 | Hormonal regulation of Pol III transcription |
| BRF1 | TFIIIB subunit, recruits Pol III | Recruitment and core binding studies |
| BDP1 | TFIIIB subunit, recruits Pol III | Recruitment and core binding studies |
How Is RNA polymerase III core binding Regulated?
Regulation of RNA polymerase III core binding and activity is responsive to cellular growth and hormonal signals. Maf1 is a conserved repressor that cooperates with progesterone receptor to repress Pol III transcription of select tRNAs, directly linking core-associated regulation to steroid hormone signaling. Recruitment of Pol III in vivo is also regulated, determining which target genes are engaged under specific conditions. These regulatory layers ensure that Pol III output matches biosynthetic demand, and their perturbation can contribute to disease.
RNA polymerase III core binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POLR3A | Neurological and developmental phenotypes | Knockout or point-mutation cell models |
| POLR3B | Pol III-related disorders | Knock-in of patient variants |
| MAF1 | Cancer and metabolic dysregulation | Overexpression and knockout models |
| PGR | Hormone-responsive cancers | Knockout and point-mutation models |
| BRF1 | Cancer and Pol III recruitment | Knockout and tagged knock-in models |
Cancer and Pol III dysregulation
Dysregulated RNA polymerase III transcription is a hallmark of many cancers, where increased tRNA and 5S rRNA production supports rapid proliferation. Core-binding factors and regulatory proteins such as Maf1 and progesterone receptor can influence Pol III output in cancer contexts, making GO:0000994 a relevant node for mechanistic studies. Structural insights into human Pol III provide a basis for interpreting cancer-associated mutations in core subunits.
Neurological and developmental disorders
Mutations in Pol III subunits have been associated with neurological and developmental phenotypes, underscoring the importance of core assembly and function. Because core binding is essential for Pol III activity, defects in core subunit interactions can impair tRNA and 5S rRNA production, with consequences for translation and cellular homeostasis. Model systems that perturb core binding can help dissect these mechanisms.
Metabolic and stress-related conditions
Pol III transcription is sensitive to metabolic and stress signals, and regulators such as Maf1 mediate repression under unfavorable conditions. Core binding and recruitment are therefore positioned at the intersection of growth signaling and translational control. Experimental models that modulate these pathways can reveal how core-binding perturbations contribute to metabolic dysfunction.
From RNA polymerase III core binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a core subunit essential for Pol III activity? | CRISPR knockout of the subunit gene |
| Does a specific residue mediate core binding? | Point-mutation knock-in of the residue |
| How does a disease variant affect core assembly? | Knock-in of the patient variant |
| Where does a core-binding protein localize? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a regulator alter Pol III output? | Overexpression cell model |
| Which genes depend on a core-binding factor? | CRISPR library screening and RNA-seq |
How to Study the RNA polymerase III core binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | Three-dimensional structure of Pol III core | Mapping subunit interfaces and binding surfaces |
| RNA-seq | Pol III target RNA levels | Assessing transcriptional output after perturbation |
| ChIP-based assays | Pol III occupancy at target genes | Measuring recruitment in vivo |
| Biochemical termination assays | Core versus holoenzyme termination | Distinguishing mechanistic pathways |
| Proteomics | Protein interaction networks | Identifying core-associated factors |
| Structural modeling | Predicted binding interfaces | Interpreting disease variants |
| Translational profiling | Protein synthesis capacity | Linking Pol III output to translation |
| CRISPR screening | Gene dependencies | Identifying regulators of Pol III core function |
Structural and biochemical approaches
Cryo-electron microscopy has been used to determine the structures of human Pol III in unbound and transcribing states, revealing core subunit organization and regulatory interfaces. Complementary structural studies have provided insights into transcriptional regulation of human Pol III. Biochemical assays can distinguish core-dependent and holoenzyme-dependent termination mechanisms, offering functional readouts for core binding.
Transcriptomic and translational profiling
RNA-seq and related approaches can measure Pol III target gene output, including tRNAs and 5S rRNA, following perturbation of core-binding factors. Translational profiling can link changes in Pol III activity to protein synthesis capacity. These methods are useful for assessing the functional consequences of core-binding perturbations.
Recruitment and chromatin assays
Recruitment of RNA polymerase III in vivo can be assessed using chromatin-based assays that measure Pol III occupancy at target genes. Such assays help determine whether core-binding factors influence recruitment or post-recruitment steps. Combining recruitment data with structural models provides a more complete picture of core binding.
Proteomic and interaction studies
Proteomic approaches can identify proteins that associate with the Pol III core and map interaction networks. Assembly studies suggest a putative co-translational mechanism, which can be probed with interaction and fractionation methods. These techniques complement structural and genetic approaches to define core-binding interfaces.
How CRISPR Can Be Used to Study GO:0000994 RNA polymerase III core binding
Knockout
CRISPR knockout of genes encoding Pol III core subunits or their binding partners can test essentiality and reveal downstream effects on tRNA and 5S rRNA production. Knockout models are particularly useful for distinguishing core-dependent from holoenzyme-dependent mechanisms.
Point Mutation
Point-mutation knock-in can be used to interrogate specific residues within core subunits or binding interfaces, allowing precise structure-function tests. Such models help determine whether a given residue is required for core binding or catalysis.
Knock-in
Knock-in of disease-associated variants or epitope tags enables functional and localization studies of Pol III core components. Tagged knock-in models facilitate interaction and imaging experiments without altering endogenous regulation.
Overexpression
Overexpression of core-binding factors or regulators such as Maf1 can reveal gain-of-function effects on Pol III transcription and cellular growth. Overexpression models complement loss-of-function approaches to define the regulatory range of core binding.
How EDITGENE Supports RNA polymerase III core binding Research
Researchers studying RNA polymerase III core binding-related genes often need to determine whether a candidate gene is causally involved in Pol III assembly, recruitment or regulation. CRISPR-based models provide a direct route to test causality, and EDITGENE offers a comprehensive suite of services to support such studies.
Contact EDITGENE today to design your custom CRISPR model for RNA polymerase III core binding research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| MAF1 Knockout HEK293 Cell Line | EDJ-KQ3083 | Human | 84232 | Details Get a Quote |
| MAF1 Knockout A-549 Cell Line | EDJ-KQ24384 | Human | 84232 | Details Get a Quote |
| MAF1 Knockout HCT 116 Cell Line | EDJ-KQ24385 | Human | 84232 | Details Get a Quote |
| MAF1 Knockout HeLa Cell Line | EDJ-KQ24386 | Human | 84232 | Details Get a Quote |
Frequently Asked Questions About RNA polymerase III core binding
What is RNA polymerase III core binding?
RNA polymerase III core binding (GO:0000994) is a molecular function describing the binding of a protein to the core enzyme of eukaryotic RNA polymerase III, a multisubunit nuclear polymerase typically composed of seventeen subunits.
What genes are involved in RNA polymerase III core binding?
Genes encoding Pol III core subunits such as POLR3A, POLR3B, POLR3C, POLR3D, POLR3E, POLR3F, POLR3G, POLR3H and POLR3K, as well as regulatory factors like MAF1, are relevant to this function.
What is the function of GO:0000994?
GO:0000994 annotates proteins that bind the Pol III core enzyme, a step important for assembly, recruitment, transcription and termination.
How is RNA polymerase III core binding regulated?
It is regulated by growth and hormonal signals, including Maf1 and progesterone receptor, which repress Pol III transcription of select tRNAs.
Why is RNA polymerase III core binding important in cancer?
Dysregulated Pol III transcription supports rapid proliferation in cancer, and core-binding factors and regulators such as Maf1 can influence this process.
What methods study RNA polymerase III core binding?
Cryo-EM, RNA-seq, ChIP-based assays, biochemical termination assays and proteomics are commonly used.
Can CRISPR be used to study RNA polymerase III core binding?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models can test the roles of core subunits and binding partners.
What is the difference between core and holoenzyme mechanisms in Pol III termination?
Core-dependent termination involves the Pol III core enzyme directly, whereas holoenzyme-dependent termination requires additional factors.
Which diseases are linked to Pol III core dysfunction?
Neurological and developmental disorders, cancer and metabolic conditions have been associated with Pol III dysregulation.
How can I model RNA polymerase III core binding in the lab?
EDITGENE offers knockout, point-mutation, knock-in, overexpression and CRISPR library screening services to model core binding and its consequences.
Conclusion
GO:0000994, RNA polymerase III core binding, defines a critical molecular interface that governs Pol III assembly, recruitment, transcription and termination. Structural and biochemical studies have illuminated the architecture of the Pol III core and the mechanisms by which it is regulated, while disease research links core dysfunction to cancer, neurological disorders and metabolic conditions. CRISPR-based models provide a powerful means to test causality and to dissect the roles of individual core subunits and binding partners. By combining precise genome editing with functional and structural readouts, researchers can advance our understanding of Pol III biology and its therapeutic potential.
References
- 1. Boguta M. 2022. Assembly of RNA polymerase III complex involves a putative co-translational mechanism.. Gene 824:146394 PMID: 35278633
- 2. Wang Q et al.. 2022. A structural perspective of human RNA polymerase III.. RNA Biol 19(1):246-255 PMID: 35133940
- 3. Arimbasseri AG et al.. 2013. Transcription termination by the eukaryotic RNA polymerase III.. Biochim Biophys Acta 1829(3-4):318-30 PMID: 23099421
- 4. Finlay-Schultz J et al.. 2025. Maf1 cooperates with progesterone receptor to repress RNA polymerase III transcription of select tRNAs.. Nucleic Acids Res 53(20) PMID: 41206048
- 5. Arimbasseri AG et al.. 2013. Distinguishing core and holoenzyme mechanisms of transcription termination by RNA polymerase III.. Mol Cell Biol 33(8):1571-81 PMID: 23401852
- 6. Wang Q et al.. 2021. Structural insights into transcriptional regulation of human RNA polymerase III.. Nat Struct Mol Biol 28(2):220-227 PMID: 33558766
- 7. Kenneth NS et al.. 2008. Recruitment of RNA polymerase III in vivo.. Nucleic Acids Res 36(11):3757-64 PMID: 18487626
- 8. Girbig M et al.. 2021. Cryo-EM structures of human RNA polymerase III in its unbound and transcribing states.. Nat Struct Mol Biol 28(2):210-219 PMID: 33558764
